Evercore ISI raised the firm’s price target on Agilent to $130 from $126 and keeps an In Line rating on the shares in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- Dynatrace initiated, U.S. Bancorp downgraded: Wall Street’s top analyst calls
- Agilent downgraded to Peer Perform from Outperform at Wolfe Research
- Agilent price target raised to $140 from $134 at BofA
- Agilent Technologies’ AI Challenge: Balancing Innovation Risk with Regulatory Compliance
- Agilent assumed with Hold from Buy at Jefferies